Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

被引:28
|
作者
Diz-Chaves, Yolanda [1 ]
Herrera-Perez, Salvador [2 ]
Gonzalez-Matias, Lucas C. [1 ]
Lamas, Jose Antonio [2 ]
Mallo, Federico [1 ]
机构
[1] Univ Vigo, Lab Endocrinol, CINBIO, Grp FB3A, Vigo 36310, Spain
[2] Univ Vigo, Lab Neurociencia, CINBIO, Grp FB3A, Vigo 36310, Spain
关键词
glucagon-like peptide-1; hypothalamic-pituitary-adrenal (HPA) axis; sympathetic nervous system (SNS); ion channels; food intake; BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL-AXIS; NUCLEUS-TRACTUS-SOLITARIUS; RECEPTOR-EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; PANCREATIC BETA-CELLS; REDUCES FOOD-INTAKE; HEART-RATE; ENERGY-BALANCE;
D O I
10.3390/nu12113304
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glucagon like-peptide 1 (GLP-1) within the brain is produced by a population of preproglucagon neurons located in the caudal nucleus of the solitary tract. These neurons project to the hypothalamus and another forebrain, hindbrain, and mesolimbic brain areas control the autonomic function, feeding, and the motivation to feed or regulate the stress response and the hypothalamic-pituitary-adrenal axis. GLP-1 receptor (GLP-1R) controls both food intake and feeding behavior (hunger-driven feeding, the hedonic value of food, and food motivation). The activation of GLP-1 receptors involves second messenger pathways and ionic events in the autonomic nervous system, which are very relevant to explain the essential central actions of GLP-1 as neuromodulator coordinating food intake in response to a physiological and stress-related stimulus to maintain homeostasis. Alterations in GLP-1 signaling associated with obesity or chronic stress induce the dysregulation of eating behavior. This review summarized the experimental shreds of evidence from studies using GLP-1R agonists to describe the neural and endocrine integration of stress responses and feeding behavior.
引用
收藏
页码:1 / 32
页数:32
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
    Unger J.R.
    Parkin C.G.
    Diabetes Therapy, 2011, 2 (1) : 29 - 39
  • [32] Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
    Mabilleau, Guillaume
    Pereira, Marie
    Chenu, Chantal
    JOURNAL OF ENDOCRINOLOGY, 2018, 236 (01) : R29 - R42
  • [33] Glucagon-like peptide-1 (GLP-1) is a powerful inhibitor of gastric emptying in man
    Näslund, E
    Skogar, S
    Grybäck, P
    Jacobsson, H
    Holst, JJ
    Hellström, PM
    GASTROENTEROLOGY, 1998, 114 (04) : A810 - A810
  • [34] Molecular simulation of zwitterionic polypeptides on protecting glucagon-like peptide-1 (GLP-1)
    Teng, Jiaman
    Liu, Yuting
    Shen, Zhuanglin
    Lv, Weizhong
    Chen, Yantao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 174 : 519 - 526
  • [35] Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum
    U. Ritzel
    A. Fromme
    M. Ottleben
    U. Leonhardt
    G. Ramadori
    Acta Diabetologica, 1997, 34 : 18 - 21
  • [36] Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning
    Basalay, Marina V.
    Mastitskaya, Svetlana
    Mrochek, Aleksander
    Ackland, Gareth L.
    del Arroyo, Ana Gutierrez
    Sanchez, Jenifer
    Sjoquist, Per-Ove
    Pernow, John
    Gourine, Alexander V.
    Gourine, Andrey
    CARDIOVASCULAR RESEARCH, 2016, 112 (03) : 669 - 676
  • [37] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Kastin, AJ
    Akerstrom, V
    Pan, WH
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 18 (1-2) : 7 - 14
  • [38] Gastrointestinal effects of glucagon-like peptide-1 (GLP-1): Mechanism of action.
    Holst, JJ
    Wojdemann, M
    Wettergren, A
    DIABETES, 1996, 45 : 859 - 859
  • [39] Glucagon-like Peptide-1 (GLP-1): 25 Years Incentive for Diabetes research
    Nauck, M. A.
    DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (05) : 367 - 372
  • [40] Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
    Koshal, Prashant
    Jamwal, Sumit
    Kumar, Puneet
    NEUROPHARMACOLOGY, 2018, 136 : 271 - 279